Browsing by Author "Nagaoka, Yutaka"

Now showing 1 - 2 of 2
  • Thumbnail Image
    Item
    Fluorinated Graphene Oxide: a New Multimodal Material for Biological Applications
    (Wiley, 2013) Romero-Aburto, Rebeca; Narayanan, Tharangattu N.; Nagaoka, Yutaka; Hasumura, Takashi; Mitcham, Trevor M.; Fukuda, Takahiro; Cox, Paris J.; Bouchard, Richard R.; Maekawa, Toru; Kumar, Sakthi; Torti, Suzy V.; Mani, Sendurai A.; Ajayan, Pulickel M.
    Fluorinated graphene oxide (FGO) is reported for the first time as a magnetically responsive drug carrier that can serve as a MRI and photoacoustic contrast agent, under pre-clinical settings, as well as a photothermal therapy Its hydrophilic nature facilitates biocompatibility. FGO as a broad wavelength absorber, with high charge transfer and strong nonlinear scattering is optimal for NIR laser-induced hyperthermia.
  • Thumbnail Image
    Item
    Multi-stimuli responsive Cu2S nanocrystals as trimodal imaging and synergistic chemo-photothermal therapy agents
    (Royal Society of Chemistry, 2015) Poulose, Aby Cheruvathoor; Veeranarayanan, Srivani; Mohamed, M. Sheikh; Nagaoka, Yutaka; Aburto, Rebeca Romero; Mitcham, Trevor; Ajayan, Pulickel M.; Bouchard, Richard R.; Sakamoto, Yasushi; Yoshida, Yasuhiko; Maekawa, Toru; Kumar, D. Sakthi
    A size and shape tuned, multifunctional metal chalcogenide, Cu2S-based nanotheranostic agent is developed for trimodal imaging and multimodal therapeutics against brain cancer cells. This theranostic agent was highly efficient in optical, photoacoustic and X-ray contrast imaging systems. The folate targeted NIR-responsive photothermal ablation in synergism with the chemotherapeutic action of doxorubicin proved to be a rapid precision guided cancer-killing module. The multi-stimuli, i.e., pH-, thermo- and photo-responsive drug release behavior of the nanoconjugates opens up a wider corridor for on-demand triggered drug administration. The simple synthesis protocol, combined with the multitudes of interesting features packed into a single nanoformulation, clearly demonstrates the competing role of this Cu2S nanosystem in future cancer treatment strategies.